Zehren brings to Endologix more than twenty years of commercial, sales and marketing, and business development experience in the medical device industry.
Most recently, he served as vice president of sales, Americas at Medtronic Neurovascular and was a senior member of the company's Neurovascular Management Board.
While at Medtronic, he developed and implemented a strategic commercial plan to double revenue in five years.
Prior to that, he spent five years as vice president of Sales at Covidien and ev3. Earlier in his distinguished career, Zehren spent over a decade at Edwards Lifesciences, the last four years of which were in the role of vice president of Sales and Marketing.
Zehren earned his Bachelor of Arts in Biology from College of St. Thomas in Minnesota.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer